Next JLM-BioCity, Sept 6th, on "PR or PERISH - How Media creates Value for a Bio Startup"
| From: | Joe van Z. |
| Sent on: | Wednesday, August 16, 2017, 3:37 PM |
The next JLM -BioCity event
"PR or Perish - How Media Creates Value for a Bio Startup" on Wednesday September 6
has been organized especially to help decision makers in bio and healthcare companies to learn how media can be used to create value for your company.
For this purpose we have invited four experts to divulge their suggestions and secrets on how an appropriate impact in the media can contribute to better investor awareness, lead generation and market interest. Abigail Leichman, Senior Writer and Associate Editor, Israel21C, one of the leading biomed reporters in Israel, will give the perspective from the media, Josh Hextor, COO & VP of Business Development, Oramed Pharmaceuticals and Ronen Segal, COO, Brainsway will present successful media strategies of two of Jerusalem's leading companies and finally Tsipi Haitovsky, Orchot Consulting give the strategic point of view, as one of the leading experts in developing media strategies for bio startups in Israel.
JLM-BioCity has created a platform on Jerusalem Bio Innovation, covering news at the different bio companies in the Jerusalem area and from the Jlm bio-ecosystem. You can join us on the linkedin group:
https://www.linkedin.com/group
or follow us on the JLM-BioCity site at
http://jlm-biocity.org/jlm-bio
The purpose of the Jerusalem Bio Innovation newsletter is:
- create a better sense of bio community in Jerusalem, where people are better informed on what is doing in the local bio industry;
- brand Jerusalem as a hot bed of Bio and Health Innovation, with a stead stream of innovations and business developments coming every week.
We need your news! To create more value both for your company and Jerusalem.
Best regards,
____________________________________________________